We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Dedicated Bioprocess Analyzer Monitors Fermenter Growth of Cell Cultures

By LabMedica International staff writers
Posted on 22 Sep 2011
A dedicated analyzer designed to provide a safe and reliable means for determining the chemical and biochemical parameters generated during fermenter growth of bacterial or mammalian cell cultures is now available for biotech and life science researchers.

The new Cedex Bio Bioprocess Analyzer is being marketed by Roche (Basel, Switzerland), one of the world’s largest producers of scientific instruments.

Cedex is a compact desktop system designed to fulfill the essential needs for metabolite screening and substrate analysis of bioprocesses. More...
It is able to perform photometric and electrolyte testing of up to 14 parameters simultaneously (out of 28 programmable tests) per sample. The instrument is easy to operate, enabling continuous loading and unloading of diverse cup types as well as having on-board dilution capability for highly concentrated samples.

The system is based on Roche’s well-known “cobas” technology and has built-in programs for the determination of glucose, lactate, LDH, ammonia, Na+, K+, glutamine, and glutamate. New parameters can be implemented by “plug and play,“ and a development channel for individual assay customization is planned.

“Bioprocess analytics are performed throughout the process from cell line development to large scale manufacturing of commercialized therapeutics. The majority of testing takes place during the upscale from plate-size to preclinical or early clinical studies supply – this is where the Cedex Bio Bioprocess Analyzer fits in perfectly. It is an accurate and reliable tool, providing bioprocess metabolite profiling, which is critical for the optimal production of biotherapeutics,” said Thomas Baier, head of global marketing for Roche Applied Science.

Related Links:
Roche




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Electrolyte Analyzer
BKE-B
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.